Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2...
Read morePhase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase 2...
Read more(TheNewswire) Un groupe financier privé mondial dont le siège social est à San Francisco conseille sur la facilité de construction...
Read more(TheNewswire) Global private financial group headquartered in San Francisco advises on construction facility to support CHARBONE’s expansion of modular green...
Read moreHere’s a quick recap of the crypto landscape for Monday (June 2) as of 9:00 p.m. UTC. Get the latest...
Read moreTesla’s long-awaited entry into the robotaxi market — expected later this month — is coming to Austin, Texas, which has...
Read moreShares of Dollar General jumped nearly 16% on Tuesday after the discounter raised its outlook, saying it drew more middle-...
Read morePeloton on Tuesday launched its own marketplace for reselling used equipment and gear as the company looks to capitalize on...
Read moreSnacktime is nigh at the Golden Arches. On June 3, McDonald’s announced exactly when the Snack Wrap will return to...
Read moreDiscover the top 10 stock charts to watch this month with Grayson Roze and David Keller, CMT. From breakout strategies...
Read moreStaples and Tech Swap Positions Again The weekly sector rotation continues to paint a picture of a market in flux,...
Read moreCopyright © 2026 investstrategiesgroup.com | All Rights Reserved